MEDXF News and Press, Medexus Pharmaceuticals Inc From 01/05/21

LOS ANGELES, CA / ACCESSWIRE / January 5, 2021 / The SNN Network Canada Virtual Event will take place on January 6-7, 2021, where 42 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. Kicking off the SNN Network Canada Virtu...

TORONTO, ON, CHICAGO, IL and MONTREAL, QC / ACCESSWIRE / January 4, 2021 / Medexus Pharmaceuticals Inc. (" Medexus " or " Company ") (TSXV:MDP) (OTCQX:MEDXF), a leading specialty pharmaceutical company with a strong North American commercial platform, today announced that it will be presenti...

TORONTO and CHICAGO and MONTREAL, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that the board of directors of the Company (the “ Bo...

Medexus Pharmaceuticals (MEDXF) announces it has entered into an exclusive license agreement with Ethypharm to register and commercialize Triamcinolone Hexacetonide in the U.S.TH is indicated for adults and adolescents for intra-articular, intrasynovial, or periarticular use in the ...

TORONTO and CHICAGO and MONTREAL, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) is pleased to announce it has entered into an exclusive license agreement wit...

TORONTO and CHICAGO and MONTREAL, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “ Medexus ”) ( TSXV: MDP , OTCQX: MEDXF ), today announced that it will be presenting at the 13 ...

Innovation Investor Conference Presentations Now Available for On-Demand Viewing NEW YORK , Dec. 7, 2020 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the Innovation Virt...

Medexus to Webcast Live at VirtualInvestorConferences.com December 3rd TORONTO and CHICAGO and MONTREAL , Dec. 2, 2020 /PRNewswire/ -- Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSXV: MDP, OTCQX: MEDXF), today announced that Ken d...

Live Innovation Investor Conference & Webinar: Public Company Presentations December 3rd Live Innovation Investor Conference & Webinar: Public Company Presentations December 3rd Company executives will share vision and answer audience questions at VirtualInvestorConf...

Medexus Pharmaceuticals (MEDXF): FQ2 Net loss of C$2M.Revenue of C$23.6M (+43.9% Y/Y)Press Release For further details see: Medexus Pharmaceuticals reports FQ2 results